Stereotactic body radiotherapy for medically inoperable lung cancer: Prospective, single-center study of 108 consecutive patients

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages 967-973

  Taremi, Mojgan ^a,b   Hope, Andrew ^a   Dahele, Max ^c   Pearson, Shannon ^a   Fung, Sharon ^a   Purdie, Thomas ^a   Brade, Anthony ^a,b   Cho, John ^a   Sun, Alexander ^a   Bissonnette, Jean Pierre ^a   Bezjak, Andrea ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Radiation Oncology Department   (Canada)

Author keywords

Image guided radiotherapy; Non small cell lung cancer; Pulmonary nodules; Radiotherapy toxicity; Stereotactic body radiotherapy

Indexed keywords

ACUTE TOXICITY; CAUSE-SPECIFIC SURVIVAL; CONFIDENCE INTERVAL; FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHIES; IMAGE GUIDED RADIOTHERAPY; LOCAL CONTROL; LUNG CANCER; MEDICALLY INOPERABLE; NON SMALL CELL LUNG CANCER; PATHOLOGIC DIAGNOSIS; PRE-TREATMENT; PULMONARY NODULES; RADIOLOGIC RESPONSE; RESEARCH ETHICS; STATISTICALLY SIGNIFICANT DIFFERENCE; STEREOTACTIC BODY RADIOTHERAPY; WHOLE-BODY;

BIOLOGICAL ORGANS; DIAGNOSIS; DISEASES; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; TUMORS;

TOXICITY;

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER CENTER; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COUGHING; DYSPEPSIA; DYSPHAGIA; DYSPNEA; FATIGUE; FEMALE; FOLLOW UP; HEMOPTYSIS; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RIB FRACTURE; SKIN TOXICITY; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; THORAX PAIN;

AGED; AGED, 80 AND OVER; CANCER CARE FACILITIES; CARCINOMA, NON-SMALL-CELL LUNG; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ONTARIO; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOPHARMACEUTICALS; RADIOSURGERY; RADIOTHERAPY, IMAGE-GUIDED; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84855843127     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.12.039     Document Type: Article

References (28)

1. N. Martini, M.S. Bains, and M.E. Burt Incidence of local recurrence and second primary tumors in resected stage I lung cancer J Thorac Cardiovasc Surg 109 1995 120 129
2. C.S. Lathan, B.A. Neville, and C.C. Earle The effect of race on invasive staging and surgery in non-small-cell lung cancer J Clin Oncol 24 2006 413 418
3. G.S. Sibley, T.A. Jamieson, and L.B. Marks Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience Int J Radiat Oncol Biol Phys 40 1998 149 154
4. R.D. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
5. F.J. Lagerwaard, C.J.A. Haasbeek, and E.F. Smith Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I NSCLC Int J Radiat Oncol Biol Phys 70 2008 685 692
6. M. Dahele, S. Pearson, and T. Purdie Practical considerations arising from the implementation of lung stereotactic body radiation therapy (SBRT) at a comprehensive cancer center J Thorac Oncol 3 2008 1332 1341
7. T.G. Purdie, D.J. Moseley, and J.P. Bissonnette Respiration correlated cone-beam computed tomography and 4DCT for evaluating target motion in stereotactic lung radiation therapy Acta Oncol 45 2006 915 922
8. J.P. Bissonnette, K.N. Franks, and T.G. Purdie Quantifying interfraction and intrafraction tumor motion in lung stereotactic body radiotherapy using respiration-correlated cone beam computed tomography Int J Radiat Oncol Biol Phys 75 2009 688 695
9. D.A. Jaffray, J.H. Siewerdsen, and J.W. Wong Flat-panel cone-beam computed tomography for image-guided radiation therapy Int J Radiat Oncol Biol Phys 53 2002 1337 1349
10. T.G. Purdie, J.P. Bissonnette, and K. Franks Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: Localization, verification, and intrafraction tumor position Int J Radiat Oncol Biol Phys 68 2007 243 252
11. A. Trotti, A.D. Colevas, and A. Setser CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181
12. P. Therasse, S.G. Arbuck, E.A. Eisenhauer European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 2000 205 216
13. M.S. Pepe, and T.R. Fleming Weighted Kaplan-Meier statistics: A class of distance tests for censored survival data Biometrics 45 1989 497 507
14. A. Takeda, E. Kunieda, and T. Takeda Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer Int J Radiat Oncol Biol Phys 70 2008 1057 1065
15. P. Baumann, J. Nyman, and M. Hoyer Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
16. R.D. Timmerman, B.D. Kavanagh, and L.C. Cho Stereotactic body radiation therapy in multiple organ sites J Clin Oncol 25 2007 947 952
17. N.A. Christie, A. Pennathur, and S.A. Burton Stereotactic radiosurgery for early stage non-small cell lung cancer: Rationale, patient selection, results, and complications Semin Thorac Cardiovasc Surg 20 2008 290 297
18. F.M. Kong, R.K. Ten Haken, and M.J. Schipper High-dose radiation improved local tumor control and overall survival in patients with inoperable/ unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study Int J Radiat Oncol Biol Phys 63 2005 324 333
19. H. Onishi, T. Araki, and H. Shrato Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study Cancer 101 2004 1623 1631
20. Y. Matsuo, Y. Nakamaoto, and Y. Nagata Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer Radiother Oncol 97 2010 200 204
21. M. Dahele, M. Freeman, and S. Pearson Early metabolic response evaluation after stereotactic radiotherapy for lung cancer: Pilot experience with FDG PET-CT Clin Oncol Epub 2010 Dec 29
22. M. Taremi, A. Hope, and P.E. Lindsay Radiotherapy induced bone injury as a late side effect in patients treated with stereotactic lung radiotherapy Int J Radiat Oncol Biol Phys 78 Suppl. 2010 S522
23. K.M. Yeow, L.C. See, and K.W. Lui Risk factors for pneumothorax and bleeding after CT-guided percutaneous coaxial cutting needle biopsy of lung lesions J Vasc Interv Radiol 12 2001 1305 1312
24. A.J. Winning, J. McIvor, and W.A. Seed Interpretation of negative results in fine needle aspiration of discrete pulmonary lesions Thorax 41 1986 875 879
25. K. Abe, S. Baba, and K. Kaneko Diagnostic and prognostic values of FDG-PET in patients with non-small cell lung cancer Clin Imaging 33 2009 90 95
26. A. Rodriguez Fernandez, M.E. Bellon Guardia, and M. Gomez Rio [Staging of non-small cell lung cancer: Diagnostic efficacy of structural (CT) and functional (FDG-PET) imaging methods] Rev Clin Esp 207 2007 541 547
27. M. Dahele, A. Brade, and S. Pearson Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer Can Med Assoc J 180 2009 1326 1328
28. T. Inoue, S. Shimizu, and R. Onimaru Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination Int J Radiat Oncol Biol Phys 75 2009 683 687